3,694
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Bortezomib-cyclophosphamide-dexamethasone induction/consolidation and bortezomib maintenance for transplant-eligible newly diagnosed multiple myeloma: phase 2 multicenter trial

, , , , , , , , , , , , , ORCID Icon, , , , , , , , , , , , , , ORCID Icon, & show all